British drugmaker AstraZeneca says it has started Phase 3 trials of its coronavirus vaccine candidate in the United States. The vaccine, AZD 1222, is the third to enter large-scale trials in the United States, after vaccines made by Moderna and Pfizer/BioNTech.
AstraZeneca’s coronavirus vaccine becomes third to begin Phase three trials in the United States
